Scholarly & Creative Works
selected scholarly works & creative activities
-
Article
-
2021STEM-08. ST6Gal1-MEDIATED SILALYLATION IS CRITICAL FOR GLIOBLASTOMA GROWTH. NEURO-ONCOLOGY. 23:vi22-vi22.Full Text via DOI: 10.1093/neuonc/noab196.083
-
2021Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathwaysFull Text via DOI: 10.1016/j.jaut.2020.102575 Web of Science: 000614250900007
-
2021Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cellsFull Text via DOI: 10.1074/jbc.RA120.014126 Web of Science: 000672866400018
-
2020Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnoverFull Text via DOI: 10.1074/jbc.RA120.014887 Web of Science: 000581643400016
-
2020Sa1210 ST6GAL-I IS UPREGULATED IN BARRETT'S ESOPHAGUS STEM CELLS AND DYSPLASIA. GASTROENTEROLOGY. 158:s-313.Full Text via DOI: 10.1016/s0016-5085(20)31482-7
-
2019156 – H. Pylori Induces Gastric Epithelial Cell Expression of Glycosyltransferase St6Gal-I in the Pathogenesis of Gastric Adenocarcinoma. GASTROENTEROLOGY. 156:s-36-s-37.Full Text via DOI: 10.1016/s0016-5085(19)36869-6
-
2019283 – The Role of St6Gal-I, a Glycosyltransferase Strongly Associated with Mucosal Carcinogenesis, in Barrett's Esophagus and Esophageal Adenocarcinoma. GASTROENTEROLOGY. 156:s-57.Full Text via DOI: 10.1016/s0016-5085(19)36927-6
-
2018716 - Glycosyltransferase ST6GAL-I Associates with WNT Signaling Molecules and is a Characteristic Marker of Mucosal Epithelial Stem Cells. GASTROENTEROLOGY. 154:s-148-s-149.Full Text via DOI: 10.1016/s0016-5085(18)30912-0
-
2018Sa1102 - Barrett's Epithelium Displays Increased Expression of St6Gal-I, a Glycosyltransferase Strongly Associated with Mucosal Carcinogenesis. GASTROENTEROLOGY. 154:s-241.Full Text via DOI: 10.1016/s0016-5085(18)31183-1
-
2016The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype. CANCER RESEARCH. 76:3978-3988.Full Text via DOI: 10.1158/0008-5472.CAN-15-2834 Web of Science: 000380071400032
-
Conference
-
2021Microenvironmental and intracellular galectin-3 govern melanoma progression. GLYCOBIOLOGY. 1689-1689.Web of Science: 000754737200035
-
2021ST6Gal1 promotes acinar to ductal metaplasia and pancreatic cancer progression. GLYCOBIOLOGY. 1688-1688.Web of Science: 000754737200033
-
2021hypoxia controls the glycobiological signature and related pro-tumorigenic properties of metastatic melanomas. GLYCOBIOLOGY. 1683-1684.Web of Science: 000754737200024
-
2021Abstract 2609: Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality. CANCER RESEARCH. 2609-2609.Full Text via DOI: 10.1158/1538-7445.am2021-2609
-
2021Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality.. CANCER RESEARCH.Web of Science: 000680263507006
-
2020GCNT2 suppression in metastatic melanoma is potentiated by hypoxia and correlates with aggressive disease progression. GLYCOBIOLOGY. 1041-1041.Web of Science: 000606577100049
-
2020Galectin-9 helps govern human B cell adhesion to and migration through human vascular endothelium.. GLYCOBIOLOGY. 1071-1071.Web of Science: 000606577100109
-
2020High expression of ST6Gal-I promotes a stem-like phenotype in pancreatic epithelial cells. GLYCOBIOLOGY. 1112-1112.Web of Science: 000606577100193
-
2018Abstract 4092: Glycosyltransferase ST6Gal-I promotes pancreatic ductal adenocarcinoma progression and metastasis. CANCER RESEARCH. 4092-4092.Full Text via DOI: 10.1158/1538-7445.am2018-4092
-
2016Abstract 2114: Glycosyltransferase ST6Gal-I protects against chemotherapy induced DNA damage and subsequent apoptosis in pancreatic adenocarcinoma cells. CANCER RESEARCH. 2114-2114.Full Text via DOI: 10.1158/1538-7445.am2016-2114
-
2016Abstract 3327: The tumor associated sialyltransferase ST6Gal-I promotes a cancer stem cell phenotype and upregulates stem-related transcription factors. CANCER RESEARCH. 3327-3327.Full Text via DOI: 10.1158/1538-7445.am2016-3327
-
-
Other Scholarly Work
-
2022Analysis of Galectin-Binding Receptors on B Cells. 565-580.Full Text via DOI: 10.1007/978-1-0716-2055-7_30
-
2019Cancer immunotherapy needs to learn how to stick to its guns. 5089-5091.Full Text via DOI: 10.1172/JCI133415 Web of Science: 000500567600011
-
-
Preprint
-
Review
-
2021Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. 294-301.Full Text via DOI: 10.1111/bjd.19891 Web of Science: 000646549800001
-
Research
principal investigator on
- Hypoxia as a driver of the metastatic melanoma glycome and its immune evasion capacity awarded by PhRMA Foundation 2021 - 2022
- Hypoxia dependent GCNT2 downregulation and immune modulation in metastatic melanoma awarded by FIU Foundation 2021 - 2022
- Targeting the Melanoma Glycome to Improve Immune Checkpoint Inhibitor Therapy awarded by FIU Foundation 2020 - 2021
Identifiers
ORCID iD
- https://orcid.org/0000-0002-6528-8602 (confirmed)
